Comparison of Tramacet Versus Percocet in Post Surgical Patients

Sponsor
Lawson Health Research Institute (Other)
Overall Status
Completed
CT.gov ID
NCT02361567
Collaborator
(none)
160
1
2
11
14.5

Study Details

Study Description

Brief Summary

Opioid naive patients are randomized to receive either TRAMACET or PERCOCET at the time of discharge following mild to moderate pain risk surgery. The following will be assessed: 1) Brief pain inventory (BPI) for the month. 2) Post operative pain management satisfaction. 3) Whether they sought any repeat opioid prescription. 4) Whether they intend to seek repeat opioid prescription. It is expected that both groups will have similar pain outcomes but those patients in the Percocet group will be more likely to seek a second prescription.

Condition or Disease Intervention/Treatment Phase
Phase 4

Detailed Description

Patient operating lists will be screened on a daily basis at identify potential patient candidates. The surgeon of note will be consulted to ensure that each patient, in their opinion, may be a candidate. If approved by the surgeon of note, the patient will then be approached in the preoperative area by a member of the research team to determine if they will consent to enrollment in the study.

Patients will be double blinded and randomized following low to moderate pain surgery (surgery in which patients do not generally require a patient controlled analgesic pump post-operatively, or require post operative analgesia beyond 14 days) to receive either tramacet 1-2 tablets orally every 4 hours prn or percocet 1-2 tablets orally every 4 prn. At time of discharge patients will recieve unidentifiable tablets in an unidentifying container of the usual dispense amount that their surgeon would standardly prescribe(range is usually between 30 and 60 tabs).

At 6 weeks patients will receive a phone call to determine a) brief pain inventory score for the month. B) if they sought a second opioid prescription. C) if they plan to seek a second script. E) satisfaction of post operative pain control on a 1-10 numerical scale f) any adverse side effects.

Study Design

Study Type:
Interventional
Actual Enrollment :
160 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Triple (Participant, Care Provider, Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
Comparison of Tramacet Versus Percocet in Post Surgical Patients
Actual Study Start Date :
Apr 1, 2015
Actual Primary Completion Date :
Mar 1, 2016
Actual Study Completion Date :
Mar 1, 2016

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Tramacet

Tramacet 1-2 tabs PO q4h prn

Drug: Tramacet
Pain medication commonly used post-operatively
Other Names:
  • tramadol/acetominophen
  • Active Comparator: Percocet

    Percocet (5/325) 1-2 tab PO q4h PRN

    Drug: Percocet
    Pain medication commonly used post-operatively
    Other Names:
  • oxycodone/acetominophen
  • Outcome Measures

    Primary Outcome Measures

    1. Sought Second Prescription [6 weeks post-operative]

      What patients have sought a second opioid prescription post operatively

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 65 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes

    Inclusion Criteria age 18-65

    opioid naïve

    postoperative from mild to moderate pain risk surgery (surgery in which patients do not generally require a patient controlled Analgesic pump post-operatively, or require post operative analgesia beyond 14 days)

    Exclusion Criteria:

    Patients on Opioids

    Children < 18 years

    Elderly

    Pregnancy

    Language barrier

    Past medical history of psychosis

    Coexisting use of anti-depressants

    American Society of Anesthesia Risk Score >3

    Known allergy to opioid or acetaminophen

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Victoria Hospital London Ontario Canada N6A 5W9

    Sponsors and Collaborators

    • Lawson Health Research Institute

    Investigators

    • Principal Investigator: Collin Clarke, MD, Lawson Health Research Institute

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Lawson Health Research Institute
    ClinicalTrials.gov Identifier:
    NCT02361567
    Other Study ID Numbers:
    • 103278
    First Posted:
    Feb 11, 2015
    Last Update Posted:
    Nov 6, 2018
    Last Verified:
    Nov 1, 2018
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Lawson Health Research Institute
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Nov 6, 2018